Zelong Liu

Inflammasome targeting with an NLRP3 agonist therapy is feasible but ineffective in murine hepatocellular carcinoma models with liver damage

H. Kikuchi, D. Duda, Z. Pu, 2022, bioRxiv.

IFNA pathway drives the more aggressive phenotype of KRASG12D-mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation

T. Shioda, R. Jain, H. Kikuchi, 2022, bioRxiv.

Tumor vessel normalization and immunotherapy in gastric cancer

Li Wang, Lu Li, D. Pu, 2022, Therapeutic advances in medical oncology.

Combination Of STING Agonist And CXCR3 Antagonist Disrupts Immune Tolerance To Overcome Anti-PD-L1 Resistance In Lung Adenocarcinoma Under Oxidative Stress.

Jingsi Dong, Shiqi Huang, Zhirong Zhang, 2022, Gene.

STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment

Fang Peng, Xuegong Fan, Z. Pu, 2022, Cancer Cell International.

Application of a novel coumarin-derivative near-infrared fluorescence probe to amyloid-β imaging and inhibition in Alzheimer's disease

Genyan Liu, Zhuoyuan Yang, Xian Chen, 2022, Journal of Luminescence.

Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy

R. Jain, L. Munn, D. Fukumura, 2023, bioRxiv.